The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Research from the University of Tokyo has demonstrated the efficacy of a small, light-activated molecule in removing clumps of amyloid protein found in the brains of mice with Alzheimer’s disease. If perfected for use in humans, the method could be used as an alternative to immunotherapy and to treat other diseases caused by similar proteins.
The molecule the researchers developed is known as a photo-oxygenation catalyst. Research team members injected it directly into the brains of live mice with Alzheimer’s disease, before illuminating it with a probe for 30 minutes each day for one week. Chemical analysis of the mouse brain tissue showed that the treatment significantly reduced amyloid protein. Additional experiments…READ MORE